Hypersound Medical, a pioneer in non-invasive neuromodulation, is proud to announce that its innovative radio-frequency–based pain therapy has been featured in the prestigious IEEE Pulse magazine. The article, titled “Zap the Pain, Skip the Pills: Noninvasive Chronic Pain Treatment With a New Spin on Radio Frequency Microwaves,” highlights Hypersound’s groundbreaking approach to chronic pain relief — offering a safe, drug-free, and surgery-free alternative to conventional treatments.
The feature recognizes Hypersound Medical’s first-in-class device that uses intersecting radio-frequency (RF) waves to create a focused, non-thermal energy field capable of precise nerve stimulation. This allows deep tissue targeting without invasive electrodes or implants — addressing the critical therapeutic gap between over-the-counter TENS units and costly surgical neurostimulators.
“Being profiled by IEEE Pulse validates not only the science but the market potential behind Hypersound’s technology,” said Tim Dickman, CEO of Hypersound Medical. “Chronic pain is one of the largest unmet medical needs globally, and our goal is to make precision neuromodulation accessible to millions without the risks, recovery time, or costs associated with surgery.”
The article emphasizes Hypersound’s non-thermal mechanism of action, which activates the body’s natural analgesic pathways without generating heat or tissue damage. Unlike traditional RF ablation or nerve blocks, Hypersound’s method provides therapeutic benefit while preserving nerve integrity. This is a serious paradigm shift in pain management.
Investment Outlook
The chronic pain treatment market exceeds $80 billion globally, driven by an urgent need for opioid alternatives and patient-directed care models. Hypersound Medical’s proprietary RF platform is positioned to:
- Serve a multi-billion-dollar segment currently underserved by both TENS and implantable devices
- Enable broad adoption in home, clinical, and hospital environments
- Align with payer and regulatory initiatives favoring non-pharmacological pain therapies
With its patent portfolio, upcoming clinical validation studies, and early-stage partnerships in health technology innovation hubs, Hypersound Medical offers a compelling growth opportunity in the rapidly expanding field of energy-based neuromodulation.
About Hypersound Medical
Hypersound Medical is a medical technology company developing non-invasive neuromodulation therapies for chronic pain and related conditions. Its proprietary hypersound RF platform uses precisely controlled microwave energy to stimulate nerve pathways without surgery, heat, or drugs — unlocking a new era of accessible, effective pain relief.
To learn more about the Hypersound technology, contact info@hypersoundmedical.com.
Investor Inquiries:
Charles Jepson
Hypersound Medical
Email: charlesj@hypersoundmedical.com